First-in-human, phase I study of AK109, an anti-VEGFR2 antibody in patients with advanced or metastatic solid tumors
AK109(一种抗VEGFR2抗体)在晚期或转移性实体瘤患者中的首次人体I期研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2023.101156
Zheng, Y; Zhong, H; Zhao, F; Zhou, H; Mao, C; Lv, W; Yuan, M; Qian, J; Jiang, H; Wang, Z; Xiao, C; Guo, J; Liu, T; Liu, W; Wang, Z M; Li, B; Xia, M; Xu, N